REMED Co., Ltd.

REMED Co., Ltd.

KKRX:302550
2,590.00
KRW
-25.00
(-0.96%)
21.52EPS
43.63P/E
88.65BMarket Cap
Mar 23Next Earn

Total Valuation

KRW

As of June 30, 2026, REMED Co., Ltd. carries a market capitalization of 88.65B, placing it among publicly traded companies globally. Its enterprise value stands at 82.91B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap88.65B
Enterprise Value82.91B

Important Dates

REMED Co., Ltd.'s next confirmed earnings release is scheduled for March 23, 2027.

Earnings Date3/23/2027

Share Statistics

As of June 30, 2026, REMED Co., Ltd. has 30.52M shares outstanding.

Shares Outstanding30.52M

Valuation Ratios

As of June 30, 2026, REMED Co., Ltd. trades at a trailing price-to-earnings ratio of 43.63. The price-to-sales ratio is 3.31, and the price-to-book ratio stands at 2.31.

PE Ratio43.63
PS Ratio3.31
PB Ratio2.31
P/TBV Ratio2.41
P/FCF Ratio1,167.97
P/OCF Ratio32.98

Enterprise Valuation

As of June 30, 2026, REMED Co., Ltd. trades at an EV/EBITDA multiple of 24.49 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.06 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 42.45 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. REMED Co., Ltd. trades at an EV/FCF ratio of 174.85, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 82.91B versus a market cap of 88.65B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales3.06
EV / EBITDA24.49
EV / EBIT42.45
EV / FCF174.85

Financial Position

As of June 30, 2026, REMED Co., Ltd. maintains a current ratio of 2.34, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 15.94, indicating elevated leverage, while an interest coverage ratio of 9.38 demonstrates adequate ability to service its debt obligations.

Current Ratio2.34
Quick Ratio0.93
Debt / Equity15.94
Debt / EBITDA1.75
Interest Coverage9.38

Financial Efficiency

KRW

Over the twelve months ended June 30, 2026, REMED Co., Ltd. posted a return on equity (ROE) of 5.17, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 4.04 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 3.79, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 7.21, useful for judging operating efficiency across full business cycles. The company generates approximately 242.62M in revenue per employee across its workforce of 111.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.59 indicates how many times REMED Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)5.17
Return on Assets (ROA)3.79
Return on Invested Capital (ROIC)4.04
Return on Capital Employed (ROCE)7.21
Revenue Per Employee242.62M
Employee Count111.50
Inventory Turnover1.59

Taxes

KRW

Over the twelve months ended June 30, 2026, REMED Co., Ltd. recorded 119.81M in income tax expense. That works out to an effective tax rate of 8.73, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 1.37B, leaving 2.05B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax119.81M
Effective Tax Rate8.73

Stock Price Statistics

KRW

As of the close on November 17, 2026, REMED Co., Ltd.'s stock has declined approximately 19.44% over the past 52 weeks. The 50-day moving average sits at 2,532.20, while the 200-day moving average is 2,828.90.

52-Week Price Change-19.44%
50-Day Moving Average2,532.20
200-Day Moving Average2,828.90

Income Statement

KRW

Over the twelve months ended June 30, 2026, REMED Co., Ltd. generated 27.05B in revenue and converted that into 2.05B in net income, yielding earnings per share of 21.52. EBITDA reached 3.39B, while operating income came in at 1.95B.

Revenue27.05B
Gross Profit15.22B
Operating Income1.95B
Pretax Income1.37B
Net Income2.05B
EBITDA3.39B
EBIT1.95B
Earnings Per Share (EPS)21.52

Balance Sheet

KRW

As of June 30, 2026, REMED Co., Ltd. holds 10.55B in cash and equivalents against 5.93B in total debt, resulting in a net debt position of -3.24B. Total book value stands at 38.30B, with working capital of 15.22B providing operational flexibility.

Cash & Cash Equivalents10.55B
Total Debt5.93B
Net Debt-3.24B
Equity (Book Value)38.30B
Book Value Per Share1,254.95
Working Capital15.22B

Cash Flow

KRW

REMED Co., Ltd. produced 2.71B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -2.57B in capital expenditures, free cash flow totaled 144.80M - equivalent to 4.70 per share.

Operating Cash Flow2.71B
Capital Expenditures-2.57B
Free Cash Flow144.80M
FCF Per Share4.70

Margins

Over the twelve months ended June 30, 2026, REMED Co., Ltd. posted a gross margin of 56.27, reflecting its pricing power and cost economics. The operating margin of 7.22 and net profit margin of 7.58 provide insight into operational efficiency.

Gross Margin56.27
Operating Margin7.22
Pretax Margin5.07
Profit Margin7.58
EBITDA Margin12.51

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 0.09, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 3.80, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to REMED Co., Ltd. shareholders.

Shareholder Yield3.80
FCF Yield0.09

Stock Splits

REMED Co., Ltd.'s most recent stock split took place on December 26, 2023 with a 1:5 split ratio.

Last Split Date12/26/2023
Split Ratio1:5

Scores

As of June 30, 2026, REMED Co., Ltd. has an Altman Z-Score of 4.45, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.45